$PURE
PURE BIOSCIENCE, INC.
CIK:0001006028|SEC Filings
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Apr. 30, 2026 |
Apr. 30, 2025 |
Apr. 30, 2026 |
Apr. 30, 2025 |
|
| Total revenue | $ 506,000 | $ 491,000 | $ 1,658,000 | $ 1,438,000 |
| Cost of goods sold | 237,000 | 208,000 | 701,000 | 603,000 |
| Gross profit | 269,000 | 283,000 | 957,000 | 835,000 |
| Operating costs and expenses | ||||
| Selling, general and administrative | 708,000 | 776,000 | 2,298,000 | 2,528,000 |
| Research and development | 79,000 | 91,000 | 239,000 | 243,000 |
| Total operating costs and expenses | 787,000 | 867,000 | 2,537,000 | 2,771,000 |
| Loss from operations | (518,000) | (584,000) | (1,580,000) | (1,936,000) |
| Other income (expense) | ||||
| Other income (expense), net | 82,000 | 8,000 | 79,000 | |
| Interest expense, net | (106,000) | (78,000) | (301,000) | (210,000) |
| Total other income (expense) | (106,000) | 4,000 | (293,000) | (131,000) |
| Net loss | $ (624,000) | $ (580,000) | $ (1,873,000) | $ (2,067,000) |
| Basic net loss per share | $ (0.01) | $ (0.01) | $ (0.02) | $ (0.02) |
| Diluted net loss per share | $ (0.01) | $ (0.01) | $ (0.02) | $ (0.02) |
| Shares used in computing basic net loss per share | 110,833,042 | 111,856,473 | 111,543,047 | 111,856,473 |
| Shares used in computing diluted net loss per share | 110,833,042 | 111,856,473 | 111,543,047 | 111,856,473 |
| Product [Member] | ||||
| Total revenue | $ 506,000 | $ 489,000 | $ 1,656,000 | $ 1,435,000 |
| Royalty [Member] | ||||
| Total revenue | $ 2,000 | $ 2,000 | $ 3,000 | |